Aurora Cannabis Introduces Daily Special™ in Germany
Aurora Cannabis Inc., a key player in the global medical cannabis industry, has expanded its offerings with the launch of Daily Special™ in the German market. This new medical cannabis brand is designed to provide patients with affordable, high-quality flower options that meet the growing demands of the market.
Meeting the Needs of Patients
The Daily Special brand aims to deliver a pharmaceutical-grade product, ensuring that patients have reliable access to medical cannabis. With the company’s commitment to quality and standard practices, the Daily Special will adhere to global GMP production standards. This launch coincides with Germany's expanding medical cannabis market, further solidifying Aurora's position as a leader in the sector.
Product Characteristics and Availability
The initial offering from the Daily Special brand features a sativa-dominant cultivar derived from Gelonade × Biscotti, boasting a THC content between 21-23% and low CBD levels of less than 1%. This unique cannabis flower promises an exhilarating sensory experience, highlighted by its vibrant citrus, sweet-earthy, and diesel-forward aromas. Patients can expect to find this product available across German pharmacies and through telemedicine platforms, effective from December 19, 2025.
A Strong Commitment to Growth
Andreas Dotterweich, Senior Vice President at Aurora Europe, expressed enthusiasm about the launch: "The introduction of Daily Special in Germany highlights our long-term investment in the nation, a critical market for medical cannabis. We are excited to support and influence the evolution of Germany's medical cannabis landscape as we continue to expand choices for patients across regions."
Aurora's Legacy in the Cannabis Industry
Aurora is well-known for its comprehensive genetics library and global portfolio of medical cannabis products. The company's ongoing commitment to innovation and quality serves as a backbone for its expansion into new markets. As manufacturers strive for excellence, Aurora remains dedicated to improving patient access, ensuring that individuals can obtain the medical solutions they need without excessive financial burden.
About Aurora Cannabis Inc.
Aurora Cannabis Inc. is dedicated to pioneering the global cannabis market, catering to both medical and recreational consumers in various regions, including Canada, Europe, Australia, and New Zealand. Located in Edmonton, Alberta, Aurora concentrates on transforming lives through the benefits of cannabis. Its diverse product lines encompass a wide range of brands, serving various markets with a focus on quality and innovation. The portfolio not only includes adult-use brands like Drift®, San Raf®, Daily Special™, Tasty's™, and Greybeard®, but also notable medical cannabis brands like Cannabis flos Aurora™, MedReleaf®, CanniMed®, and more.
The company also owns a controlling stake in Bevo Farms Ltd., a leading supplier of cultivated agricultural plants in North America. By investing in science and the highest product standards, Aurora drives success in both medical and recreational cannabis markets.
Frequently Asked Questions
What is the Daily Special™ launched by Aurora?
Daily Special™ is a new medical cannabis brand introduced by Aurora, aimed at providing patients in Germany with high-quality and affordable cannabis options.
Where can I find Daily Special™ products?
Customers can purchase Daily Special™ products at pharmacies and via telemedicine platforms throughout Germany, starting from December 19, 2025.
What type of strain is included in the Daily Special™ launch?
The launch includes a sativa-dominant cultivar derived from Gelonade × Biscotti, with THC levels ranging from 21-23%.
How does Aurora ensure product quality?
Aurora follows rigorous GMP production standards to guarantee that products meet pharmaceutical-grade quality, maintaining consistency and reliability for consumers.
What is Aurora Cannabis Inc.'s mission?
Aurora is committed to improving the lives of consumers by providing innovative cannabis solutions while expanding its reach in both the medical and recreational markets globally.
